Kiora Pharmaceuticals, Inc. Common Stock

KPRXNASDAQUSD
2.57 USD
0.07 (2.65%)🟢PRE MARKET (AS OF 04:15 PM EDT)
🟢Market: OPEN

KPRX is currently priced at $2.57. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Aug 13, 2026.

Open?$2.64
High?$2.66
Low?$2.52
Prev. Close?$2.64
Volume?12.6K
Avg. Volume?19.6K
VWAP?$2.60
Rel. Volume?0.64x
Bid / Ask
Bid?$2.20 × 100
Ask?$3.00 × 100
Spread?$0.80
Midpoint?$2.60
Valuation & Ratios
Market Cap?11.5M
Shares Out?4.4M
Float?4.3M
Float %?96.9%
P/E Ratio?N/A
P/B Ratio?0.68
EPS?-$2.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
Employees
13
Market Cap
11.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-02-13
Address
169 SAXONY RD.
ENCINITAS, CA 92024
Phone: 858-224-9600
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-9.16Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.09%Low
Short Interest?3.9K
Days to Cover?1.0
Free Float4.3M
Avg Daily Volume26.0K
Settlement Date2026-07-31
Financial Health
Current Ratio?8.97Strong
Quick Ratio?8.97Strong
Cash Ratio?2.99Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.68CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.5CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-65.2%WEAK
ROA?
S&P
3
-46.2%WEAK
Cash Flow & Enterprise
FCF?$-8613878
Enterprise Value?$4.4M
Fundamentals ratios updated end of day